Genomic mutations with amino acid substitutions of circulating hepatitis B virus found in non-B, non-C patients with hepatocellular carcinoma

Nobuhiro Nakamoto, Hidetsugu Saito, Hirotoshi Ebinuma, Shinichiro Tada, Yoshimasa Saito, Satoshi Kurita, Kumi Kitamura, Hiromasa Ishii

Research output: Contribution to journalArticle

Abstract

Objective. Most hepatocellular carcinoma (HCC) in Japan is caused by chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). HBV DNA has been detected in the serum and liver tissue of some proportion of those patients who are HBs antigen-negative and HCV antibody-negative; i.e., non-B, non-C (NBNC) patients with HCC. We sought to detect HBV DNA in the serum from NBNC HCC cases and to investigate genomic mutations of HBV in seronegative cases. Patients and Methods. The sera from 26 NBNC HCC patients were examined by polymerase chain reaction (PCR) followed by southern blotting for existence of HBV DNA. The precore/core and polymerase regions of the HBV genome in the sera from five seronegative cases were analyzed by direct sequence. Results. HBV DNA was detected in 17 of 26 patients (65.4%). Demographic factors such as age, gender, anti-HBs positivity, anti-HBc positivity, complication with cirrhosis, and excessive alcohol intake did not affect circulating HBV positivity. Genomic mutations with amino acid substitutions were detected in the polymerase and the precore regions from one of the five cases, and in the core region from four of the five cases. Conclusions. PCR-based HBV screening is necessary in patients suffering from liver diseases of unknown etiology, although its etiological importance and benefit of viral elimination have not been established. Genomic mutations in the precore/core and the polymerase region detected in this study might be involved in the lack of HBsAg in NBNC HCC cases.

Original languageEnglish
Pages (from-to)322-330
Number of pages9
JournalInternal Medicine
Volume42
Issue number4
Publication statusPublished - 2003 Apr 1

Fingerprint

Amino Acid Substitution
Hepatitis B virus
Hepatocellular Carcinoma
Mutation
DNA
Serum
Polymerase Chain Reaction
Hepatitis C Antibodies
Hepatitis B Surface Antigens
Southern Blotting
Hepacivirus
Liver Diseases
Japan
Fibrosis
Alcohols
Demography
Genome
Antigens
Liver
Infection

Keywords

  • Carcinogenesis
  • Occult hepatitis B virus infection
  • Polymerase chain reaction
  • Sequence

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Genomic mutations with amino acid substitutions of circulating hepatitis B virus found in non-B, non-C patients with hepatocellular carcinoma. / Nakamoto, Nobuhiro; Saito, Hidetsugu; Ebinuma, Hirotoshi; Tada, Shinichiro; Saito, Yoshimasa; Kurita, Satoshi; Kitamura, Kumi; Ishii, Hiromasa.

In: Internal Medicine, Vol. 42, No. 4, 01.04.2003, p. 322-330.

Research output: Contribution to journalArticle

@article{cb18300d28824ca58fb3ad32c6198f5e,
title = "Genomic mutations with amino acid substitutions of circulating hepatitis B virus found in non-B, non-C patients with hepatocellular carcinoma",
abstract = "Objective. Most hepatocellular carcinoma (HCC) in Japan is caused by chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). HBV DNA has been detected in the serum and liver tissue of some proportion of those patients who are HBs antigen-negative and HCV antibody-negative; i.e., non-B, non-C (NBNC) patients with HCC. We sought to detect HBV DNA in the serum from NBNC HCC cases and to investigate genomic mutations of HBV in seronegative cases. Patients and Methods. The sera from 26 NBNC HCC patients were examined by polymerase chain reaction (PCR) followed by southern blotting for existence of HBV DNA. The precore/core and polymerase regions of the HBV genome in the sera from five seronegative cases were analyzed by direct sequence. Results. HBV DNA was detected in 17 of 26 patients (65.4{\%}). Demographic factors such as age, gender, anti-HBs positivity, anti-HBc positivity, complication with cirrhosis, and excessive alcohol intake did not affect circulating HBV positivity. Genomic mutations with amino acid substitutions were detected in the polymerase and the precore regions from one of the five cases, and in the core region from four of the five cases. Conclusions. PCR-based HBV screening is necessary in patients suffering from liver diseases of unknown etiology, although its etiological importance and benefit of viral elimination have not been established. Genomic mutations in the precore/core and the polymerase region detected in this study might be involved in the lack of HBsAg in NBNC HCC cases.",
keywords = "Carcinogenesis, Occult hepatitis B virus infection, Polymerase chain reaction, Sequence",
author = "Nobuhiro Nakamoto and Hidetsugu Saito and Hirotoshi Ebinuma and Shinichiro Tada and Yoshimasa Saito and Satoshi Kurita and Kumi Kitamura and Hiromasa Ishii",
year = "2003",
month = "4",
day = "1",
language = "English",
volume = "42",
pages = "322--330",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "4",

}

TY - JOUR

T1 - Genomic mutations with amino acid substitutions of circulating hepatitis B virus found in non-B, non-C patients with hepatocellular carcinoma

AU - Nakamoto, Nobuhiro

AU - Saito, Hidetsugu

AU - Ebinuma, Hirotoshi

AU - Tada, Shinichiro

AU - Saito, Yoshimasa

AU - Kurita, Satoshi

AU - Kitamura, Kumi

AU - Ishii, Hiromasa

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Objective. Most hepatocellular carcinoma (HCC) in Japan is caused by chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). HBV DNA has been detected in the serum and liver tissue of some proportion of those patients who are HBs antigen-negative and HCV antibody-negative; i.e., non-B, non-C (NBNC) patients with HCC. We sought to detect HBV DNA in the serum from NBNC HCC cases and to investigate genomic mutations of HBV in seronegative cases. Patients and Methods. The sera from 26 NBNC HCC patients were examined by polymerase chain reaction (PCR) followed by southern blotting for existence of HBV DNA. The precore/core and polymerase regions of the HBV genome in the sera from five seronegative cases were analyzed by direct sequence. Results. HBV DNA was detected in 17 of 26 patients (65.4%). Demographic factors such as age, gender, anti-HBs positivity, anti-HBc positivity, complication with cirrhosis, and excessive alcohol intake did not affect circulating HBV positivity. Genomic mutations with amino acid substitutions were detected in the polymerase and the precore regions from one of the five cases, and in the core region from four of the five cases. Conclusions. PCR-based HBV screening is necessary in patients suffering from liver diseases of unknown etiology, although its etiological importance and benefit of viral elimination have not been established. Genomic mutations in the precore/core and the polymerase region detected in this study might be involved in the lack of HBsAg in NBNC HCC cases.

AB - Objective. Most hepatocellular carcinoma (HCC) in Japan is caused by chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). HBV DNA has been detected in the serum and liver tissue of some proportion of those patients who are HBs antigen-negative and HCV antibody-negative; i.e., non-B, non-C (NBNC) patients with HCC. We sought to detect HBV DNA in the serum from NBNC HCC cases and to investigate genomic mutations of HBV in seronegative cases. Patients and Methods. The sera from 26 NBNC HCC patients were examined by polymerase chain reaction (PCR) followed by southern blotting for existence of HBV DNA. The precore/core and polymerase regions of the HBV genome in the sera from five seronegative cases were analyzed by direct sequence. Results. HBV DNA was detected in 17 of 26 patients (65.4%). Demographic factors such as age, gender, anti-HBs positivity, anti-HBc positivity, complication with cirrhosis, and excessive alcohol intake did not affect circulating HBV positivity. Genomic mutations with amino acid substitutions were detected in the polymerase and the precore regions from one of the five cases, and in the core region from four of the five cases. Conclusions. PCR-based HBV screening is necessary in patients suffering from liver diseases of unknown etiology, although its etiological importance and benefit of viral elimination have not been established. Genomic mutations in the precore/core and the polymerase region detected in this study might be involved in the lack of HBsAg in NBNC HCC cases.

KW - Carcinogenesis

KW - Occult hepatitis B virus infection

KW - Polymerase chain reaction

KW - Sequence

UR - http://www.scopus.com/inward/record.url?scp=0038663173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038663173&partnerID=8YFLogxK

M3 - Article

C2 - 12729320

AN - SCOPUS:0038663173

VL - 42

SP - 322

EP - 330

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 4

ER -